Skip to main navigation Skip to search Skip to main content

Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center

  • Lotte Kleinendorst
  • , Ozair Abawi
  • , Bibian van der Voorn
  • , Mieke H.T.M. Jongejan
  • , Annelies E. Brandsma
  • , Jenny A. Visser
  • , Elisabeth F.C. van Rossum
  • , Bert van der Zwaag
  • , Mariëlle Alders
  • , Elles M.J. Boon
  • , Mieke M. van Haelst
  • , Erica L.T. van den Akker*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Downloads (Pure)

Abstract

BACKGROUND: Underlying medical causes of obesity (endocrine disorders, genetic obesity disorders, cerebral or medication-induced obesities) are thought to be rare. Even in specialized pediatric endocrinology clinics, low diagnostic yield is reported, but evidence is limited. Identifying these causes is vital for patient-tailored treatment.

OBJECTIVES: To present the results of a systematic diagnostic workup in children and adolescents referred to a specialized pediatric obesity center.

METHODS: This is a prospective observational study. Prevalence of underlying medical causes was determined after a multidisciplinary, systematic diagnostic workup including growth charts analysis, extensive biochemical and hormonal assessment and genetic testing in all patients.

RESULTS: The diagnostic workup was completed in n = 282 patients. Median age was 10.8 years (IQR 7.7-14.1); median BMI +3.7SDS (IQR +3.3-+4.3). In 54 (19%) patients, a singular underlying medical cause was identified: in 37 patients genetic obesity, in 8 patients cerebral and in 9 patients medication-induced obesities. In total, thirteen different genetic obesity disorders were diagnosed. Obesity onset <5 years (p = 0.04) and hyperphagia (p = 0.001) were indicators of underlying genetic causes, but only in patients without intellectual disability (ID). Patients with genetic obesity with ID more often had a history of neonatal feeding problems (p = 0.003) and short stature (p = 0.005). BMI-SDS was not higher in patients with genetic obesity disorders (p = 0.52). Patients with cerebral and medication-induced obesities had lower height-SDS than the rest of the cohort.

CONCLUSIONS: To our knowledge, this is the first study to report the results of a systematic diagnostic workup aimed at identifying endocrine, genetic, cerebral or medication-induced causes of pediatric obesity. We found that a variety of singular underlying causes were identified in 19% of the patients with severe childhood obesity. Because of this heterogeneity, an extensive diagnostic approach is needed to establish the underlying medical causes and to facilitate disease-specific, patient-tailored treatment.

Original languageEnglish
Article numbere0232990
Number of pages22
JournalPLoS ONE
Volume15
Issue number5
DOIs
Publication statusPublished - May 2020

Keywords

  • Adolescent
  • Ambulatory Care Facilities
  • Brain Diseases/complications
  • Child
  • Child, Preschool
  • Drug-Related Side Effects and Adverse Reactions/diagnosis
  • Endocrine System Diseases/complications
  • Female
  • Genetic Testing
  • Humans
  • Infant
  • Infant, Newborn
  • Intellectual Disability/complications
  • Male
  • Netherlands
  • Pediatric Obesity/diagnosis
  • Phenotype
  • Prospective Studies

Fingerprint

Dive into the research topics of 'Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center'. Together they form a unique fingerprint.

Cite this